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ABSTRACT
High-throughput sequencing technologies, includ-
ing RNA-seq, have made it possible to move be-
yond gene expression analysis to study transcrip-
tional events including alternative splicing and gene
fusions. Furthermore, recent studies in cancer have
suggested the importance of identifying transcrip-
tionally altered loci as biomarkers for improved prog-
nosis and therapy. While many statistical methods
have been proposed for identifying novel transcrip-
tional events with RNA-seq, nearly all rely on con-
trasting known classes of samples, such as tumor
and normal. Few tools exist for the unsupervised dis-
covery of such events without class labels. In this pa-
per, we present SigFuge for identifying genomic loci
exhibiting differential transcription patterns across
many RNA-seq samples. SigFuge combines cluster-
ing with hypothesis testing to identify genes exhibit-
ing alternative splicing, or differences in isoform ex-
pression. We apply SigFuge to RNA-seq cohorts of
177 lung and 279 head and neck squamous cell car-
cinoma samples from the Cancer Genome Atlas, and
identify several cases of differential isoform usage
including CDKN2A, a tumor suppressor gene known
to be inactivated in a majority of lung squamous cell
tumors. By not restricting attention to known sample
stratifications, SigFuge offers a novel approach to
unsupervised screening of genetic loci across RNA-
seq cohorts. SigFuge is available as an R package
through Bioconductor.
INTRODUCTION
Today, massively parallel next-generation sequencing plat-
forms offer unbiased analysis of transcriptomes at higher
accuracy and resolution than microarrays (1). Beyond mea-
suring expression levels, transcriptome sequencing (RNA-
seq) can be used to discover novel transcriptional events
such as splicing patterns (2), alternative untranslated region
usage (3) and gene fusions (4). With the rise of platforms
capable of producing large-scale genomic datasets, unsu-
pervised methods have played an increasingly major role in
the analysis of such data. Arguably, among unsupervised
approaches, clustering methods have had the most visible
impact on the field. Briefly, clustering methods provide the
ability to discover grouping structure within datasets with-
out knowledge of a priori classes. In past studies, hierar-
chical clustering has been applied to microarray expression
profiles to identify clinically relevant subclasses of cancers
and other diseases (5–7). As such, extensions of these ap-
proaches tomodern sequencing platforms could potentially
be used to identify unrecognized structure with applications
to a variety of problems.
An emerging area of genomic research is the identifica-
tion of alternative splicing events, i.e. when pre-mRNAs are
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spliced in different ways to produce distinct isoforms, ulti-
mately encoding for different proteins (8). Recent estimates
suggest that most human genes are alternatively spliced,
with most alternative exons showing tissue-specific regula-
tion (9). Further, alternative splicing and isoform selection
have been implicated as determinants of cell type and speci-
ficity (10). Within individual samples, multiple isoforms are
often simultaneously expressed at a single gene. Therefore,
identifying differential isoform usage, where multiple iso-
forms of a single gene are expressed, but at different pro-
portions between groups of samples, may provide insight
into the functional consequences of a disease.
Throughout this paper, we will refer to a region of the
genome to which a single gene has been annotated as a lo-
cus. Using RNA-seq, expression at a single gene, or locus,
can now bemeasured at each base-position along the length
of the transcript, making the technology sensitive to iso-
form level changes in expression. Thus, genome-wide dis-
covery of alternate isoformusage is an opportunity afforded
by RNA-seq, beyond what was possible using gene expres-
sion arrays. Our approach is motivated by the desire to re-
alize the full potential of RNA-seq data.
Several methods have been suggested for the detection of
alternative splicing or isoform differences in supervised set-
tings, e.g. in a tumor versus normal comparison, including
Cuffdiff 2 (11), DEXSeq (12) and DiffSplice (13). However,
differences in isoform usage may not always correspond to
known class labels, e.g. differential usage may exist between
subsets of a single tissue type. As an example, the usage of
a novel CDH3 splice variant was reported in only a subset
(8/20) of adenocarcinoma tumors relative to normal (14).
In this case, the differential signal may become lost within
the larger tumor versus normal comparison, and further,
the subtype behavior completely missed. Currently, it is not
clear how to identify differential isoform usage when the ap-
propriate stratification of samples is unknown.
To address these problems, unsupervised approaches, in-
cluding clustering, have complemented supervised analyses
in genomics. Earlier on, approaches to whole-genome clus-
tering, i.e. clustering by gene expression across all loci, were
proposed for RNA-seq data (15). More recently, SIBER
(16) and DEXUS (17) have been proposed for clustering
samples at the single gene level, i.e. clustering at each gene
separately, to discover novel subpopulations exhibiting dif-
ferential expression at individual loci. However, these meth-
ods were not specifically designed to detect differences in
isoform usage as they only consider gene-level expression.
In order to detect subsets, or clusters, of RNA-seq sam-
ples with alternative forms or patterns of isoform usage,
we have developed SigFuge (SIGnificant Forms Using per-
base Gene Expression). SigFuge aims to identify clusters
that express isoforms from a single gene locus at differing
proportions. That is, we seek to identify clusters with dif-
fering isoform preferences at the level of single genes. This
is possible because SigFuge uses expression levels at each
base-position across a gene locus. Briefly, for each locus,
the approach first requires filtering out lowly expressed sam-
ples. Then, among the remaining samples, SigFuge normal-
izes expression at the base-pair level. This normalization
allows SigFuge to emphasize expression differences occur-
ring throughout a segment of the gene, e.g. exon-level dif-
ferences, while ignoring differences occurring across the en-
tire gene, e.g. whole gene gain/loss, which methods such
as SIBER and DEXUS aim to identify. Next, the samples
are clustered into two subpopulations by the normalized
base-pair level expression, and finally, a significance test is
performed to quantify the strength of evidence supporting
a difference in isoform usage between the two subpopula-
tions. SigFuge is available as an R package through Bio-
conductor.
In this paper, we first describe SigFuge using a simple
toy example. We then compare the performance of our
method against the closest competing approaches, DEXUS
and SIBER, through an extensive simulation study. Finally,
we apply our method to collections of lung squamous cell
carcinoma (lung SQCC) and head and neck squamous cell
carcinoma (head and neck SQCC) RNA-seq samples from
the Cancer Genome Atlas (TCGA). We show that SigFuge
identifies important transcriptional alterations including al-
ternative splicing of the tumor suppressor gene CDKN2A.
These results demonstrate that SigFuge is a powerful tool
for identifying genes exhibiting differential isoform usage
across large RNA-seq cohorts.
MATERIALS AND METHODS
SigFuge method
We describe the SigFuge method in three major parts: data
extraction, processing and analysis. A pipeline of the com-
plete approach is given in Figure 1A, with blue boxes used
to distinguish the three parts. In the next subsections, we
describe each part in detail, motivating our approach using
a hypothetical Gene A across a cohort of 60 RNA-seq sam-
ples. To replicate the variation observed in RNA-seq data,
per-base-position read counts were obtained from 60 of the
lung SQCC samples along a subset of the bases within the
FAM64A locus.
Data extraction. Consider Gene A having two known iso-
forms differing by a single cassette (middle) exon (Fig-
ure 1B). We first study three samples that represent impor-
tant modes of expression in the larger cohort of 60 samples:
(i) low expression across the entire gene,
(ii) primary expression of isoform 1,
(iii) primary expression of isoform 2.
The differences in mRNA product are clearly reflected
in the corresponding per-base read depths, plotted on the
log-scale (Figure 1C). From this, we propose characterizing
gene expression at the per-base resolution to study differ-
ential isoform usage. More specifically, we define a sample
expression profile at a given gene to be the vector of per-base
read depths across the exons of the union gene. In our toy
example, the union gene, formed by combining all isoforms,
is simply isoform 2 (Figure 1B). The resulting data struc-
ture is an expression count matrix with rows corresponding
to samples, and columns corresponding to positions across
the gene model (Figure 1D). This count matrix serves as
the input to the computational steps of SigFuge, and can
be obtained, for example, from BAM files using the SAM-
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using separate panels for each sample (Figure 1C), we prefer
a more compact visualization where expression profiles are
overlaid as curves in a single figure (Figure 1E). Note that
the empty regions of Figure 1C corresponding to introns
are excluded from the expression profiles of Figure 1E.
While exon annotations are not explicitly required for
SigFuge, as each base-position is treated with equal weight,
their use leads to more naturally interpretable results by
restricting attention to expressed regions of the locus, e.g.
in obtaining Figure 1E from Figure 1C. Similarly, our ap-
proach does not require information about the possible iso-
forms composing a gene model. This is a major strength of
the method, as the precise structure of isoforms may be un-
known.
Data processing. In Figure 1F–J, we consider the complete
collection of 60 expression curves (samples) along Gene A.
The goal of SigFuge is to determine whether the sample-set
contains subgroups, or clusters, exhibiting different isoform
usage. An example of differential isoform usage would be a
subset of samples that only express isoform 1 while all re-
maining samples express both isoforms 1 and 2 in equal pro-
portions. Since we are not interested in whole-gene changes
in expression, we first perform a normalization of the sam-
ple curves to make identifying clusters of differential iso-
form usage easier. The normalization procedure is broken
into the three following steps:
(i) Filtering: removing low-expression samples,
(ii) Count normalizing: scaling expression curves to have
equal total coverage,
(iii) Log-transformation: mapping count data, which vary
by orders of magnitude, to a more natural scale.
Since our interest is in differential isoform usage, sam-
ples not expressing any isoforms of the gene are first re-
moved from the analysis, forming a separate cluster of low-
expression samples. Specifically, at each locus we exclude
samples with over 90% of base-positions having zero cov-
erage, as well as samples with median coverage of less than
five reads across covered positions. In the toy example, low-
expression samples are colored red in Figure 1G and com-
pletely removed from Figure 1H. Next, count normaliza-
tion is used to remove differences in overall gene expres-
sion between samples. To do this, each remaining sample
is scaled by its total expression across the gene, i.e. by the
corresponding row sum of the count matrix. While several
approaches have been proposed for the normalization of
RNA-seq expression data (19–21), these approaches were
developed for genome-wide normalization, with the goal
of identifying differentially expressed genes. In contrast, we
aim to identify isoform imbalances at individual gene loci
by identifying curves exhibiting different shapes, regardless
of overall expression. Therefore, rather than employing nor-
malization procedures for genome-wide differences (e.g. li-
brary sizes), we instead use a simple per-gene approach.
Note that this normalization procedure assumes that each
locus contains a single gene and may not be appropriate
for loci containing multiple genes. Lastly, the scaled count
data are log-transformed (Figure 1H). Log-transformation
is used to study counts on the scale of relative expression,
and is often applied when data vary over several orders of
magnitude, as with read counts. To ensure the log is always
well defined, i.e. to handle zero counts, all scaled values
are increased by 1 prior to transformation. Note that zero
counts remain at zero after transformation. As shown in
Figure 1H, normalization reduces sample variability across
most of the gene (exons 1 and 3), and highlights regionswith
non-uniform usage across samples (exon 2).
Data analysis. Following normalization,K-means cluster-
ing (22) for two clusters (K = 2) using Euclidean distance is
applied to the normalized samples to identify clusters corre-
sponding to differential isoform usage. In Figure 1H, these
clusters, colored blue and green, differ noticeably by their
use of exon 2. Here, SigFuge accurately captures clusters of
samples with differing preferences for isoforms 1 and 2.
Translating the cluster labels to the original expression
profiles, i.e. coloring the data by clusters, verifies that the
identified clusters indeed correspond to clear differential
patterns across Gene A (Figure 1I). To emphasize the no-
tion of isoform clusters, we visualize the toy example us-
ing principal component analysis (23), an exploratory anal-
ysis tool for identifying low-dimensional structure in high-
dimensional data (Figure 1J). The log-transformed raw data
are projected along the first two principal component di-
rections and colored according to the results of SigFuge.
The plot clearly reveals three distinct clusters, showing the
protocol accurately captures the main modes of variation
among the samples.
This toy example was generated such that the clusters rep-
resent clearly differential patterns of expression. However,
often loci considered in practice will only possess a single ex-
pression pattern. This may correspond to loci with a single
dominant isoformor expression ofmultiple isoforms in sim-
ilar proportions across all samples. As an exploratory tool,
K-means identify clusters regardless of whether they repre-
sent true underlying structure. An important, yet difficult
task in cluster analysis is to distinguish natural clustering
from artificial clustering generated by the chosen algorithm.
In the present context, this corresponds to distinguishing
the small subset of genes with clusters exhibiting true differ-
ential isoform usage from the large number of genes across
the entire transcriptome. To address this issue, SigFuge cal-
culates a p-value quantifying the statistical significance of
clustering at each locus. The SigFuge p-values can then be
used to order a large set of genes to identify a subset of loci
most likely to exhibit true differential isoform usage. An ap-
proach for determining the regions of differential usage is
described in Supplementary Methods S3.
The p-value calculation is carried out using Statistical
Significance of Clustering (SigClust) (24). Briefly, SigClust
is a simulation-based hypothesis test proposed for analyz-
ing clustering when the number of measurements greatly
exceeds the number of observations. The procedure tests
whether the two observed clusters are tighter than would
be expected if the samples were drawn from a single Gaus-
sian cluster. If the clusters are tighter, e.g. if the expression
profiles are generated from two distinct patterns, we expect
to observe a smaller p-value. For SigClust, the tightness of
clusters is quantified using the 2-means cluster index (CI), a
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clustering with two clusters. The behavior of the 2-means
CI under the single Gaussian null is approximated using
a large number of simulated null datasets. In our genome-
wide analysis, we restrict the number of simulations to 100
for each gene.We then fit a Gaussian distribution to the 100
observed null 2-means CIs and report the lower tail prob-
ability of this fitted Gaussian as our approximate p-value,
as described in (24). Although these p-values are not exact,
they give a good sense of the relative significance of genes,
which otherwise report equivalent empirical p-values of 0.
While SigFuge may be used to test for the statistical signif-
icance of clusters obtained using any algorithm, K-means
clustering is used as it has favorable properties for the Sig-
Clust testing procedure, as noted in (24). For the clustering
shown in Figure 1H, SigFuge reports a significant p-value
of 2.1 × 10−7. A more in-depth discussion of the SigClust
assumptions as they pertain to our application can be found
in Supplementary Methods S1 and Supplementary Figure
S1. Finally, our analysis is restricted toK= 2 clusters as the
SigClust methodology is currently only capable of testing
for statistical significance with two subgroups. However, we
note that other existing unsupervised approaches, such as
SIBER and DEXUS, also seek a binary partition of obser-
vations, the latter separating between a single major condi-
tion and all remaining minor conditions.
When applying SigFuge to a large number of genes, we
suggest using an appropriate statistical procedure for con-
trolling either the family-wise error rate or false discovery
rate (FDR). We use the Benjamini–Hochberg step-up pro-
cedure to control the FDR (25).
Exon analysis
Commonly, RNA-seq-based expression data are obtained
by aggregating and processing the per-base count data,
which form the basis for our SigFuge approach. Measures
such as RPKM (reads per kilobase per million mapped
reads) (19) provide expression summaries of either the en-
tire gene, or a portion of the gene, e.g. a transcript or an
exon. These summaries are generally based on annotations
obtained from public datasets such as RefSeq (26). As a pre-
liminary assessment of any advantages to retaining the per-
base resolution over more conventional summaries of the
data, the SigFuge analysis was repeated using exon expres-
sion values, quantified by RPKM. In this analysis, for each
gene, an exon expression matrix was passed to the process-
ing and analysis steps of Figure 1A. The expression thresh-
old was set such that samples having no exons with RPKM
>1 were removed.
Simulated RNA-seq study
An extensive simulation study was carried out at the level
of single gene loci for varying experimental conditions.
Datasets were simulated with several values of sample size,
depth, dispersion and underlying isoform structure. For
each simulation, per-base expression profiles were gener-
ated from an underlying genemodel encoding two isoforms.
Toy diagrams for the gene models used in the simulations
are shown in Supplementary Figure S6. These include a
three-exon gene model containing a cassette exon, as in
Figure 1, and a four-exon gene model containing alternate
cassette exons, such that two three-exon transcripts are en-
coded using distinct second exons. Expression profiles along
a single gene locus were generated from two subpopulations
differing only by their isoform preferences. That is, sam-
ples from the two subpopulations were simulated with the
same expected gene-level expression, but with differing ex-
pected isoform-level expressions. The null setting with no
differential behavior was also considered by setting the iso-
form preferences to be equal between the two subpopula-
tions. A negative binomial distribution was used to gener-
ate isoform-level expression. Candidate values for the dis-
persion parameter, φ, were chosen as the quartiles of a log-
normal distribution estimated in (27) for the Gilad dataset
(28). A more detailed description of how datasets were gen-
erated is given in SupplementaryMethods S2. Additionally,
sample coverage plots for each of the five forms of differen-
tial isoform usage are given in Supplementary Figure S7.
Simulations were repeated 100 times.
Each simulated single gene dataset was analyzed using
SigFuge, DEXUS and SIBER. While DEXUS and SIBER
were originally described for gene-level analysis, to make
the approaches more comparable to SigFuge, bothmethods
were applied to read counts at the following three levels of
aggregation: (1) whole gene, (2) exon and (3) disjoint 100bp
windows. DEXUS results were called significant accord-
ing to the default informative/non-informative (I/NI) value
threshold of the accompanying R implementation. Signifi-
cance for the results of SIBER were determined based on
a bimodality index (BI) cutoff described in Table 1 of (16)
for controlling FDR at 0.05. Results for SIBER are not re-
ported for total sample sizes <50, as BI cutoffs were only
provided for sample sizes of 50, 100, 200 and 300. Since no
clear approach exists for aggregating across multiple tests
with the respective I/NI and BI output of DEXUS and
SIBER, for the exon and 100bp window implementations
of these two methods, loci were determined to be signifi-
cant if any exon or window was called significant with no
correction for multiple testing. SigFuge results were called
significant at a p-value cutoff of 0.05.
In addition to single gene simulations, a joint simulation
of 10 000 genes was also considered, including 9000 null
genes with no subpopulation behavior and 1000 non-null
genes with varying levels of differential usage. Each sim-
ulated gene was again analyzed using SigFuge, as well as
DEXUS and SIBER applied at three levels of aggregation.
The SigFuge p-value, DEXUS I/NI and SIBER BI output
were recorded for each simulated gene. As above, for the
exon and 100bp window implementations of DEXUS and
SIBER, the maximum I/NI and BI output were used to ag-
gregate across the multiple tests. A more thorough descrip-
tion of the joint simulation setting is given in Supplemen-
tary Methods S2.
TCGA lung squamous cell RNA-seq data
A collection of 177 lung SQCC RNA-seq samples was ob-
tained from the TCGA Research Network. The dataset
was processed as described in (29). The SAMtools depth
function was used to obtain per-base read counts. Union
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Table 1. Results for select simulation settings, with parameters: n1, n2 (subpopulation sample sizes), d (gene length), μ (gene-level read depth) and φ
(isoform-level dispersion). Parameter values n1, n2 = 50, 50; d= 1200; μ = 100; ϕ = 0.179 are treated as baseline, and deviations are marked by underlined
values. For each setting, the numbers of significant calls out of 100 replications are reported for the default implementation of SigFuge, and DEXUS and
SIBER at the gene, exon and 100bp levels of aggregation. The mean (standard deviation, SD) runtimes for single replications are reported in seconds for
SigFuge, and DEXUS and SIBER at the 100bp level. Occasionally, NAs were reported in the output of SIBER. In this case, we mark the output with
an asterisk (*m) and report the number of significant calls out of m < 100 simulations. For non-null simulations (settings 2, 3), the method with highest
sensitivity is highlighted in bold. Complete simulation results may be found in Supplementary Table S3
Simulation parameters SigFuge DEXUS SIBER
Setting n1, n2 d μ φ bp Runtime (SD) Gene Exon 100bp Runtime (SD) Gene Exon 100bp Runtime (SD)
1 100 1200 100 0.179 2 6.82 (0.31) 0 0 1 0.58 (0.01) 5 7 14 1.46 (0.26)
1 100 1200 500 0.369 7 6.59 (0.18) 0 2 2 0.58 (0.01) 2 5 9 1.55 (0.31)
1 20 1200 100 0.179 1 3.29 (0.14) 17 48 79 0.16 (0.01) – – – –
2 50, 50 1200 100 0.179 89 6.77 (0.23) 0 13 21 0.60 (0.01) 1 11 25 1.51 (0.26)
2 75, 25 1200 100 0.179 98 6.86 (0.24) 0 10 17 0.60 (0.03) 2 16 21 1.47 (0.26)
2 10, 10 1200 100 0.179 38 3.24 (0.12) 23 76 86 0.17 (0.00) – – – –
2 100, 100 1200 100 0.179 98 11.5 (0.21) 0 0 0 1.16 (0.01) 0 9 18 2.51 (0.40)
2 50, 50 1200 100 0.087 100 6.71 (0.18) 0 47 52 0.41 (0.02) 3 86 91 1.08 (0.14)
2 50, 50 1200 100 0.369 62 6.66 (0.18) 0 10 16 0.40 (0.01) 2 3 4*99 0.94 (0.22)
3 50, 50 1200 100 0.179 99 6.82 (0.18) 0 23 33 0.62 (0.11) 3 26 38 1.50 (0.17)
3 75, 25 1200 100 0.179 60 6.80 (0.19) 0 56 72 0.61 (0.01) 1 13 15 1.40 (0.19)
3 10, 10 1200 100 0.179 29 3.25 (0.16) 14 93 96 0.17 (0.00) – – – –
aries for 20 500 genes were obtained from the TCGA
generic annotation file v2.1 (https://tcga-data.nci.nih.gov/
docs/GAF/GAF.hg19.June2011.bundle/outputs/) based on
the December 2009 version of the UCSC Gene annota-
tions. Methylation, mutation and copy number calls for the
CDKN2A locus were also obtained from the supplementary
data for (29).
TCGA head and neck squamous cell RNA-seq data
A collection of 279 head and neck SQCC RNA-seq sam-
ples was obtained from the TCGA Research Network. The
dataset was processed as described in (29). Per-base read
counts were extracted for 20 500 genes as described above.
Gel polymerase chain reaction validation
One novel event identified in the lung SQCC analysis, oc-
curring at the KLK12 locus, was selected for parallel struc-
tural validation. To validate our identified isoform clusters
in KLK12, gel polymerase chain reaction (PCR) was car-
ried out on two representative samples. RNA was reverse
transcribed to cDNA using an iScript Reverse Transcrip-
tion kit (Bio-Rad, Hercules, CA, USA) according to man-
ufacturer’s instructions. Amplification of the KLK12 gene
cDNA was performed using primers described previously
(30). Briefly, 300ng of cDNA were amplified in a 50L re-
action containing 0.4M of each primer, 0.2M dNTPs,
1U of iProof High-Fidelity DNA Polymerase and its corre-
sponding buffer (Bio-Rad, Hercules, CA, USA). Reactions
were performed using a Bio-Rad C1000 thermocycler and
the following cycling conditions: 98o C for 30 seconds, 35
repeats of 98 oC for 30 seconds, 68 oC for 50 seconds and
72 oC for 1 minute, followed by a final extension at 72 oC
for 5 minutes. PCR products were resolved on a 2% agarose
gel and results documented using a VersDoc gel imaging
system (Bio-Rad, Hercules, CA, USA).
Software availability
SigFuge is available in R as a package through Biocon-
ductor (http://www.bioconductor.org/packages/devel/bioc/
html/SigFuge.html). In addition to methods for clustering
and calculating significance, the package includes functions
for creating plots of per-base expression (expression plots)
corresponding to our analysis approach. Figures 1E–I, 3
and 4 were constructed using this package.
RESULTS
Simulated RNA-seq analysis
To evaluate the performance of SigFuge under varying ex-
perimental conditions, simulation studies were carried out
at the level of single gene loci and as a joint simulation of
10 000 loci. Results of representative simulations from the
single gene study are presented in Table 1, with complete
simulation results available in Supplementary Table S3. In
Table 1, we report results for three simulation settings: (1)
no differential behavior, (2) differential usage with a three-
exon gene model and (3) differential usage with a four-exon
gene model. The corresponding three and four-exon gene
models are shown in Supplementary Figures S6 and S7. For
each setting and combination of simulation parameters, i.e.
row in Table 1, we report the number of significant calls over
100 replications of a single gene dataset. Here, the 100 repli-
cations serve to capture the sampling variation across repli-
cations of the experiment, and are not meant to represent a
collection of 100 independent genes in a single experiment.
To help orient the reader, consider the fourth row in Table
1. Under Simulation Setting 2, with subpopulation sample
sizes 50 and 50, transcript length 1200, average depth 100
and dispersion 0.179, over 100 replications we observed 89
true positive calls by SigFuge, and 0, 13 and 21 true posi-
tive calls by DEXUS applied at the gene, exon and 100bp
levels of aggregation. Similarly, we observed 1, 11 and 25
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Figure 1. The SigFuge approach is illustrated through a hypothetical example Gene A with two true isoforms differing by a single cassette exon. (A) A
general outline is given for the complete SigFuge pipeline. (B) The gene model includes two isoforms. (C) Read count pile-ups for samples 1, 2 and 3 show
low expression (top, red), expression of isoform 1 (middle, green) and expression of isoform 2 (bottom, blue), respectively. (D) The expression curves are
analyzed as a (sample × base) matrix representation of read counts. (E) The SigFuge approach studies these expression profiles as curves along the union
gene model of the locus. (F) We consider a collection of 60 unlabeled samples atGene A. (G) To study expression patterns, lowly expressed samples (colored
red) are first excluded. (H) The remaining samples are count normalized, log-transformed and clustered using K-means clustering. The clusters are clearly
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Figure 2. ROC curves are shown for SigFuge and six competing approaches applied to 10 000 simulated gene loci. Comparisons are given for SigFuge p-
values and (A) DEXUS I/NI indices and (B) SIBER BI indices at the gene, exon and 100bp window levels. The corresponding AUC is reported for each
method in the legends, and vertical black lines are used to denote the 95% specificity cutoff.
Setting 1. We first considered the null setting with no sub-
population differences. For all parameter values considered,
SigFuge made only the expected number of false positive
calls at the 0.05 significance level. Similarly, SIBER and
DEXUS make few false positive calls for the larger sam-
ple size (n = 100). However, when the sample size was de-
creased (n= 20), DEXUS produced a large number of false
significant calls across all levels of aggregation. With both
DEXUS and SIBER, more false significant calls were ob-
served at finer levels of aggregation, i.e. using exon and
100bp windows, as no correction was made for multiple
testing at these levels.
Setting 2. This setting features differential usage across
a three-exon gene model encoding for two isoforms, with
samples drawn from subpopulations 1 and 2 expressing the
isoforms at proportions 1:3 and 3:1, respectively. Notably,
SigFuge consistently provided high sensitivity, with the ex-
ception of when sample size was decreased (n1, n2 = 10, 10).
Furthermore, we observed expected trends across all meth-
ods, with sensitivity decreasing with increasing dispersion
(φ), and increasing with greater sample size (n1, n2). In most
settings other than low dispersion (φ = 0.087), DEXUS and
SIBER showed low sensitivity across all levels of aggrega-
tion, with the exception of DEXUS showing high sensitiv-
ity with lower sample size. However, care is needed in inter-
preting this because of the poor specificity shown above for
DEXUS in this context.
Setting 3. In this setting, we considered similar differential
usage as in Setting 2, using a four-exon gene model. Sam-
ples were again drawn from two subpopulations expressing
two isoforms at proportions 1:3 and 3:1. Similar results were
observed as in Setting 2, with the exception of increased sen-
sitivity by DEXUS and decreased sensitivity by SigFuge in
the unbalanced sample size setting (n1, n2 = 75, 25). In gen-
eral, sensitivity for both DEXUS and SIBER were higher
in Setting 3, likely due to the regions of differential usage
comprising a larger proportion of the entire gene.
Joint setting. A joint simulation of 10 000 genes, includ-
ing 9000 null and 1000 non-null genes was also performed
to further evaluate the sensitivity and specificity of SigFuge,
DEXUS and SIBER. The resulting receiver operating char-
acteristic (ROC) curves for each method are given in Fig-
ure 2, and corresponding summary statistics are reported in
Table 2, including area under the ROC curve (AUC), sen-
sitivity and the F1-measure (the harmonic mean of preci-
sion and recall) (31). Across all metrics, SigFuge performs
the best, with DEXUS consistently outperforming SIBER.
Although the exon and 100bp window implementations
of DEXUS achieve nearly the same AUC as SigFuge, the
DEXUS-based approaches achieve substantially lower sen-
sitivity when specificity is constrained to be above 90 or
95%.
In general, SigFuge was found to produce higher sen-
sitivity and lower false positive calls than either DEXUS
or SIBER. Additionally, in both Settings 2 and 3, DEXUS
and SIBER benefited substantially from aggregating at the
exon and 100bp window level. Finally, we note that for all
settings, SigFuge required the most computational time,
with DEXUS requiring the least. This is a consequence
of the simulation-based p-value calculation implemented
by SigFuge and the underlying SigClust algorithm. How-
ever, as computational times differ with available hard-
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Figure 3. Three genes identified as being significant by SigFuge with differential usage of middle exons (Cat. 1) are shown: (A) CDKN2A, (B) FAM64A,
and (C) KLK12. For each gene, the SigFuge clusters are shown using separate colors and panels. Each red, green and blue curve represents an individual
sample and darker bold curves are used to denote the cluster medians. Regions of differential usage, identified by visual inspection, are highlighted in the
figure for each gene. Alternating orange and blue are used to denote annotated exon boundaries.
Table 2. Summary statistics for the joint simulation, including AUC, sen-
sitivity at 90 and 95% specificity (TPR90, TPR95), and the F1-measure at
90 and 95% specificity (F190, F195).
Method AUC TPR95 TPR90 F195 F190
SigFuge-bp 0.73 0.41 0.49 0.44 0.41
DEXUS-gene 0.51 0.06 0.11 0.08 0.11
DEXUS-exon 0.66 0.25 0.34 0.29 0.30
DEXUS-100bp 0.68 0.24 0.34 0.28 0.30
SIBER-gene 0.51 0.03 0.06 0.04 0.06
SIBER-exon 0.62 0.13 0.17 0.16 0.17
SIBER-100bp 0.56 0.12 0.17 0.15 0.16
as a relative, rather than absolute, comparison of compu-
tational cost across the evaluated methods. Furthermore,
since SigFuge is applied at each locus separately, themethod
may be easily parallelized on a cluster to reduce the total
computing time for larger scale analyses.
Lung SQCC analysis
To illustrate the power of our approach in real data, we ap-
plied SigFuge to a set of 177 lung SQCC samples. Of the 20
500 genes considered, 3547 genes having <10 samples pass-
ing the expression threshold were removed from the anal-
ysis. Genes of this type were empirically considered to be
expressed at such low levels in so few samples that cluster-
ing results would be of little interest. The distribution of the
remaining 16 953 p-values is shown in Supplementary Fig-
ure S2.
Controlling FDR at 5%, 322 genes were identified
as showing significant differential patterns of expression.
Manual review of the expression at these genes suggested
Table 3. Six consistent patterns of differential usage were identified.
Cat. Name Count Representative genes
1 Cassette exon 27 CDKN2A, KLK12, FAM64A
2 Outliers 67 APRT, RABAC1, TSPO
3 Differential use of 5′- exons 50 SPATA21, SMN1, CKMT1A
4 Differential use of 3′- exons 15 RPL22L1, CRHR1, ECE2
5 Alternative start sites 53 RPS8, RPL7A, RPL35A
6 Likely mapping artifacts 110 S100A7, HLA-DRB1, RPL27
that SigFuge identified a limited number of recurring pat-
terns. Thus, the set of 322 genes was separated into six cat-
egories by visually inspecting the corresponding expression
plot at each locus (Table 3). Genes placed in the same cate-
gory were determined to exhibit similar patterns of differen-
tial isoform usage. While these categories do not necessarily
correspond to unique regulatory events, they help summa-
rize the various types of differences detectable by SigFuge.
A complete list of the top 322 genes and their correspond-
ing categories and SigFuge p-values may be found in Sup-
plementary Table S1.
The first five categories, containing potentially biologi-
callymeaningful behavior, include: (1) skipping of a cassette
exon, (2) outlier behavior, i.e. differential usage in less than
five samples, (3) differential use of the 5′- end, (iv) differen-
tial use of the 3′-end and (v) alternative start sites. Further
details on how genes were divided among the six categories
may be found in Supplementary Results S1.
In Figure 3, we show the expression plots for three genes
with differential usage of a cassette exon (Cat. 1), each de-
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of differential expression along the transcript is highlighted
in purple. Additionally, in Figure 4A, we show APRT, an
example of a genewith one clear outlier sample (Cat. 2), and
provide examples of genes from Categories 3–5 in Supple-
mentary Figure S3. We primarily focus on the set of genes
in Category 1, as their functional impact is most directly
predicted.
Events deemed likely to be artifacts of current RNA-seq
technologies and alignment algorithms, such as short un-
mapped exons (S100A7, Figure 4B), are included in Cate-
gory 6. Previous studies have shown that many split-read
alignment algorithms have difficulty aligning reads to short
exons, especially when overall gene expression is low (32).
Thus, it is highly likely that the identified clusters at S100A7
simply correspond to samples falling above and below the
threshold for properly aligning reads to the first exon.
The set of Category 1 genes includes 27 loci identified
based on apparent gain or loss of a middle exon. We will
now describe in detail three notable genes from this cate-
gory for which differential isoform usage may play a role in
tumor development and growth: CDKN2A, FAM64A and
KLK12.
CDKN2A locus. CDKN2A is a tumor suppressor gene
known to code for two proteins, p16INK4a and p14ARF. Re-
cently, CDKN2A was identified as one of the most highly
altered genes in lung SQCC (29). In the union gene model
shown in Figure 3A, expression of exons 1−3−5 encodes
for p14ARF, and expression of exons 2−3−5 encodes for
p16INK4a. Thus, the SigFuge classes correspond to expres-
sion of neither protein due to low expression (red class), ex-
pression of p16INK4a and p14ARF (green class) and expres-
sion of p14ARF only (blue class).
Table 4 compares the SigFuge clusters against the three
major modes of CDKN2A inactivation identified by the
TCGA integrative analysis: homozygous deletion, epige-
netic silencing bymethylation and inactivation by pointmu-
tation. As can be seen by the clear diagonal structure of
the table, the SigFuge clusters approximately capture the
three classes of alterations. Notably, 64% of samples in the
blue class were methylated, including all but one methy-
lated sample in the cohort. Furthermore, 96% of samples
identified as low expression (red class) were homozygous
deleted, comprising 82% of homozygous deleted samples in
all clusters, confirming the validity of our proposed filtering
scheme. Pearson’s chi-square (χ2) tests were applied to each
row of Table 4 and the entire table. The highly significant p-
values further confirm the strong association between our
SigFuge clusters and the previously identified alterations.
FAM64A locus. FAM64A is a gene that has been impli-
cated in the regulation of cell proliferation, suggesting a
possible role in cancer (33). Further, FAM64A has been
shown to be highly expressed in leukemia, lymphoma and
other tumor cell lines (34). The plot of FAM64A expression
shows clustering based on an unannotated splice junction,
resulting in lower expression for a large proportion of the
final exon (Figure 3B). Although the event has been pre-
viously reported as a retained intron (35), the implication
of the isoform difference has yet to be described. This sup-
Table 4. CDKN2A agreement between SigFuge labels and genomic alter-
ation status.
SigFuge label
Red Green Blue Total χ2 p-value
Homozygous deleted 46 0 8 54 3 × 10−15
Mutated 0 29 3 32 4 × 10−11
Methylated 1 0 41 42 ≈ 0
None 1 36 12 49 3 × 10−9
Total 48 65 64 177 ≈ 0
ports our use of per-base expression, as analysis based on
aggregation along exon or whole gene boundaries would
have likely missed this event.
KLK12 locus. KLK12 is part of a family of 15 kallikrein-
related peptidases (KLK genes) encoding secreted serine
proteases.KLK splice variants are receiving increased atten-
tion as potential biomarkers in cancer, and have been stud-
ied in epithelial ovarian, prostate and lung cancers (36–38).
TheKLK12 locus is known to produce multiple isoforms,
largely differing by the use of a cassette exon, exon 4 (Fig-
ure 3C, exon 4). A recent study has shown expression of the
exon 4 skipping isoform to be clinically relevant in breast
cancer (30). The identified KLK12 expression clusters cap-
ture evidence of similar differential usage in our cohort of
177 samples. These results support the potential of KLK12
and other KLK splice variants as markers in lung SQCC.
To confirm our identified clusters were not an artifact of
sequencing, we performed gel PCR at the KLK12 gene lo-
cus on representative samples from each of the green and
blue classes in Figure 3C. Our results confirm the absence
of isoforms retaining exon 4 in the sample from the blue
class (Supplementary Figure S4).
Exon analysis
To examine whether the same transcriptional alterations
could be identified using exon-level rather than base-level
expression values, we performed a similar clustering analy-
sis using exon RPKM values at each gene locus. Of the 20
500 genes considered, 4243 were excluded from the analysis
for having <10 samples passing the expression threshold.
Of the remaining 16 257 genes, 1898 genes were considered
significant by a FDR cutoff of 5%. The distribution of all
16 257 p-values is shown in Supplementary Figure S5, and a
list of the top 1898 genes identified by exon-level clustering,
and their corresponding p-values may be found in Supple-
mentary Table S2.
Of the 322 genes significant by our per-base SigFuge
analysis, only 27 were identified as significant in the exon-
level analysis. Of these, only five genes were from Cate-
gory 1. The three genes considered in Figure 3, CDKN2A,
FAM64A andKLK12 had respective SigClust-like p-values:
0.011, 1.05e −28 and 0.9225, with only FAM64A consid-
ered significant by the FDR threshold. However, the signif-
icant clusters identified at FAM64A by exon-level expres-
sion completely miss the differential usage at exon 6 shown
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Figure 4. Representative genes for two common patterns of differential expression are shown: (A) a single outlier sample (Cat. 2), APRT and (B) an
unmapped short starting exon (Cat. 6), S100A7. Alternating orange and blue are used to denote annotated exon boundaries. Red, blue and green represent
clusters of low expression, isoform usage 1 and isoform usage 2. Bold lines denote cluster median expression.
analysis were inconsistent with those shown in Figure 3 for
all three genes (Supplementary Figure S5).
Here, we note that the exon-based analysis is simply a
modification of the SigFuge approach, and may be consid-
ered an additional contribution of our work. Thus, while
not investigated further, loci significant by the exon-level
analysis may also reveal interesting transcriptional behav-
ior, further validating our approach to clustering by alter-
nate transcription patterns at single genes.
Head and neck SQCC analysis
As an attempt to confirm the results identified in lung
SQCC, SigFuge was also applied to an independent set
of 279 head and neck SQCC samples, a biologically sim-
ilar tumor type. Controlling FDR at 5%, 335 genes were
identified as exhibiting significant differential usage. No-
tably, we identified similar clusters of differential isoform
usage at the CDKN2A, KLK12 and FAM64A loci shown in
Figure 3 (Supplementary Figure S8). Of the three, KLK12
and FAM64A were included in the set of 335 significant
head and neck SQCC genes with p-values 1.99e−15, and
6.76e−6.While not included in the top 335 genes,CDKN2A
was also found to exhibit strong evidence of differential iso-
form usage (p-value 0.0021, 381st most significant). Fur-
ther, of the 27 Category 1 genes identified in lung SQCC, 21
(78%) were also identified as significant in head and neck
SQCC, suggesting the reproducibility of most interesting
events across different datasets.
DISCUSSION
The introduction of RNA-seq has fundamentally trans-
formed genomic research in cancer by making it possible
to study transcriptomes at the resolution of base positions.
Concurrently, the importance of studying isoform regula-
tory behavior beyond whole gene events has become in-
creasingly clear. SigFuge is presented as a novel method
capable of unsupervised discovery of differential isoform
events in RNA-seq. Our approach to studying gene expres-
sion as per-base expression curves along transcriptome co-
ordinates makes it possible to identify differential events
without strictly constraining our analysis to proposed exon
or transcript boundaries. However, we also note that as
shown in our analysis, the approach may be easily extended
to cluster based on exon-level expression, if desired. Fur-
thermore, SigFuge could potentially be extended for the
analysis of exon arrays in addition to RNA-seq, although
more testing would be necessary to determine whether
our normalization procedure would require any modifi-
cation. Our implementation of SigFuge as an R package
through Bioconductor makes the approach easily accessi-
ble for many investigators.
Through simulation study, we have shown that SigFuge
is often capable of detecting true differential isoform usage
with higher sensitivity thanDEXUS and SIBER across var-
ious experimental conditions. This may be attributed to the
unique multivariate approach taken by SigFuge, in which
all base positions and exons are considered simultaneously
to detect and assess clustering. In contrast, DEXUS and
SIBER cluster marginally at individual genes or exons, thus
rendering the approaches less sensitive to isoform differ-
ences which occur non-uniformly, but in concert, across the
entire gene. In addition to having high sensitivity, we have
shown that in the absence of subpopulation differences,
SigFuge does not make more than the expected number of
false positive calls.
Applying SigFuge to a cohort of lung SQCC samples, we
identified CDKN2A, a tumor suppressor gene known to be
highly altered in lung SQCC, and KLK12, a gene recently
shown to have differential isoform usage in breast cancer.
To our knowledge, SigFuge is the only unsupervised ap-
proach to identifying loci with significant differential iso-
form usage. All other genome-wide methods for identifying
genes with differential isoform usage require a priori knowl-
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be used to identify these events. The biological relevance of
our CDKN2A clusters was validated by observed high con-
cordance with homozygous deletion, methylation and point
mutation events at the locus. Further, the predicted isoforms
of KLK12 were confirmed by PCR as a validation of the
method.Additionally,many of the clusters identified in lung
SQCC were found to reproduce in an independent analysis
of 279 head and neck SQCC samples, suggesting that our
discoveries relate to biologically meaningful events.
The importance of alternative splicing in the develop-
ment of diseases, including cancer, is well recognized (39,
40). SigFuge shows promise as a tool for identifying biolog-
ically relevant cases of aberrant isoform usage. Given clin-
ical outcomes, testing clusters of differential isoform usage
for significant associations with survival could potentially
reveal novel therapeutic targets.
A major benefit of SigFuge is the calculation of a p-
value to quantify significance of clustering. Using the p-
value, it becomes possible to screen a large set of genes to
identify a small subset of potentially biologically interest-
ing loci. However, our post-hoc analysis makes it clear that
identifying truly interesting events is not simply a statistical
endeavor, i.e. finding significant SigFuge p-values. That is,
some loci identified by SigFuge as statistically significant,
may on manual review appear to be artifacts introduced
by sequencing and mapping challenges beyond our control.
Therefore, manual review of statistically significant results
is strongly recommended. To this end, our approach to visu-
alizing expression profiles makes it possible to quickly gain
intuition at each locus to determine the nature of the under-
lying event.
In our analysis, to allow for a quick and interpretable
evaluation of the results, SigFuge was implemented only in
regions defined by annotated genes. However, gene anno-
tations may be incomplete or inexact, reducing our power
to detect novel isoform and splicing differences. A desir-
able modification of the current approach would be to use a
guided gene discovery tool such as Cufflinks (41) or Scrip-
ture (42) to supplement the current annotation with addi-
tional candidate exons. Such an extension would allow a
more unbiased exploration of the transcriptome and may
lead to the discovery of additional alternative isoform us-
age events with SigFuge.
We conclude by introducing several proposed extensions
of the current SigFuge approach. First, as seen in our ap-
plication to the lung SQCC dataset (Figure 4 and Table 4),
SigFuge is capable of identifying outlier events with few
samples showing significantly altered transcriptional pat-
terns. These outlier events may be attributable to unique
fusion events or single nucleotide polymorphisms (SNPs)
resulting in alteration of the start or end site of a gene. In
some cases, these events may correspond to the loss of a tu-
mor suppressor gene.While additional modifications would
be needed to increase the specificity of SigFuge to these
events, this presents an interesting direction of further de-
velopment.
A limitation of the current SigFuge approach and under-
lying SigClust algorithm is the restriction to testing with
only K = 2 clusters. An extension of SigClust to handle
greater than two clusters could provide substantial bene-
fit for SigFuge as well as more general applications. We are
actively pursuing such an extension in related but separate
work.
Finally, we propose extending SigFuge to more directly
incorporate splicing information. In addition to estimat-
ing read depth at a higher resolution, RNA-seq also pro-
vides direct evidence for splicing through junction-spanning
reads. Recently, methods such as SplicingCompass (43)
have proposed using junction coverage to study differential
splicing behavior. While the SigFuge approach only makes
use of per-base coverage, it is not difficult to imagine com-
bining the two sources of information to obtain a more
complete view of isoform usage. As the number of junc-
tions and the distribution of their coverage differ substan-
tially from that of per-base expression, further investigation
is necessary before moving forward. However, we believe
that this direction shows great potential, and is actively ad-
vancing this work.
Recent genomics studies using RNA-seq are beginning to
shed light on the sheer prevalence and importance of post-
transcriptional events across the human genome. In this pa-
per, we have proposed the first approach for the unsuper-
vised discovery of differential isoform usage in RNA-seq
data. By taking the novel approach of clustering by per-base
expression, we believe SigFuge is a step in the right direction
for realizing the full potential of RNA-seq for understand-
ing the genomic complexity of diseases.
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